45 digests, newest first, page 3 of 3, browse the folder on GitHub
Sep 6, 2026, 10 items
The FDA has approved a combination therapy for muscle-invasive bladder cancer. This treatment involves pembrolizumab, or pembrolizumab with berahyaluronidase alfa-pmph,...
Also covers Corporate Update - Financial Reporting, Corporate Culture - Intern Q&A Session, Industry Event - Healthcare Conference Presence and 6 more.
Sep 6, 2026, 10 items
This article expresses gratitude to fathers and father figures for their support and guidance. It highlights their roles as protectors, healers, and pillars of hope.
Also covers Father's Day - Global Perspective, Father's Day - Support for Cancer Patients, Biomedical Research - Enhanced Contextual Understanding and 6 more.
Sep 6, 2026, 10 items
This article briefly describes a team's observance of Stroke Month and their dedication to improving stroke patient care.
Also covers AI in Healthcare - Lung Cancer Screening in Goa, FDA-Approved c-MET IHC Test - Non-Squamous NSCLC, Digital Pathology in Prostate Cancer - Expert Discussion and 6 more.
Sep 6, 2026, 10 items
Truveta will be attending the ASCO25 conference in Chicago to discuss cancer research, real-world evidence, and improving patient outcomes.
Also covers Protein Generation - PEGSSummit Talk, Healthcare - Nucleus Ambassador Program, Cell Therapy Manufacturing - Robotic Precision and 6 more.
Jul 15, 2026, 9 items
Vepdegestrant has received approval as a monotherapy for ESR1 mutated, advanced breast cancer.
Also covers Healthcare Management - Physician Workload and Administrative Burden, AI in Medicine - AI-Driven Immune Insights for Sports Medicine, Pharmaceutical Regulation - Camizestrant Regulatory Setback and 5 more.